Therapeutics Information for Providers

This page is for health care providers. Looking for Test to Treat sites near you?

Providers: Just want to use the site finder? Go to Treatment Finder for Providers and People with Prescriptions

Latest Updates

June 8, 2022

  • Therapeutics memo to all North Carolina clinicians: Updated guidance for providers about outpatient treatment and prevention of COVID-19 in patients who are at high risk of progressing to severe disease. Key updates include: Statement on limited bebtelovimab availability and expected NC supply to be depleted in August 2022, information regarding COVID-19 rebound, and updated overview of Veklury (remdesivir) since gaining full FDA approval. Read the memo. 

May 24, 2022

  • The CDC issued a Health Alert Network (HAN) Health Advisory to update health care providers, public health departments, and the public on the potential for recurrence of COVID-19 or “COVID-19 rebound.” Paxlovid continues to be recommended for early-stage treatment of mild to moderate COVID-19 among persons at high risk for progression to severe disease. Paxlovid treatment helps prevent hospitalization and death due to COVID-19. COVID-19 rebound has been reported to occur between two and eight days after initial recovery and is characterized by a recurrence of COVID-19 symptoms or a new positive viral test after having tested negative. A brief return of symptoms may be part of the natural history of SARS-CoV-2 (the virus that causes COVID-19) infection in some persons, independent of treatment with Paxlovid and regardless of vaccination status. Read the full advisory.

View All Updates by Date

Product Summaries and Allocation Requests

Providers who want to receive allocations of new therapeutic products as they are released will need to register through NCDHHS and the federal portal following the instructions provided by NCDHHS.

Provider Resources

Provider Office Hours

Join the NCDHHS COVID-19 Therapeutics Team for our monthly office hours (typically the second Friday of the month, at 12 p.m. ET) to discuss updates to and address questions related to all COVID-19 Therapeutics.

  • Join on Teams
  • Or call in (audio only): +1 984-204-1487 (Conference ID: 450 669 154#)

More Resources

Need Help?

Submit inquiries, issues and feedback to the Therapeutics Mailbox (

All Updates by Date

Have questions? We're here to help.
Submit inquiries, issues and feedback to the Therapeutics Mailbox (